Hongyu Zhou
Capital Medical University
10 Papers
7 Citations
Hongyu Zhou is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
Liping Liu,Weiqi Chen,Hongyu Zhou,Wanying Duan,Shujuan Li,Xiaochuan Huo,Weihai Xu,Li'an Huang,Huaguang Zheng,Jingyi Liu,Hui Liu,Yufei Wei,Jie Xu,Yongjun Wang +13 more
- 01 Jun 2020
TL;DR: This updated guideline presents a framework for the management of ischaemic cerebrovascular diseases, which emphasises on pathogenesis evaluation, intravenous thrombolysis, endovascular therapy, antiplatelet therapy, prevention and treatment of complications, and risk factor management.
270
Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack.
Hongyu Zhou,Anxin Wang,Xia Meng,Jinxi Lin,Yong Jiang,Jing Jing,Yingting Zuo,Yilong Wang,Xingquan Zhao,Hao Li,Yongjun Wang +10 more
- 25 Feb 2021
TL;DR: Wang et al. as discussed by the authors examined the relationship of serum albumin with poor functional outcome and mortality in patients with acute ischaemic stroke (AIS) or transient ischeemic attack (TIA), and performed a meta-analysis to summarise the association.
38
Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update
Liping Liu,Zixiao Li,Hongyu Zhou,Wanying Duan,Xiaochuan Huo,Weihai Xu,Shujuan Li,Ximing Nie,Huihui Liu,Jinjie Liu,Dapeng Sun,Yufei Wei,Guitao Zhang,Weizhuang Yuan,Lina Zheng,Jingyi Liu,David T. Wang,Zhongrong Miao,Yongjun Wang +18 more
TL;DR: This guideline updated the recommendations for the clinical management of ischaemic cerebrovascular disease from 2019 and included revisions of 15 existing recommendations and 136 new recommendations in the following areas of stroke care.
28
Effect of sex differences on prognosis of intravenous thrombolysis: data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
Hongyu Zhou,Weiqi Chen,Yuesong Pan,Yue Suo,Xia Meng,Hao Li,Yongjun Wang +6 more
- 01 Mar 2021
TL;DR: For Chinese patients with ischaemic stroke, although women are older and more severe at the time of onset, the prognosis after intravenous thrombolysis is not significantly different from men.
9
Lp-PLA2 Activity and Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack.
Jinxi Lin,Hongyu Zhou,Yubo Wang,Aoming Jin,Shangzhi Li,Ling Zhang,Xia Meng,Xuewei Xie,Jing Jing,Yong Jiang,Yilong Wang,Xingquan Zhao,Hao Li,Zixiao Li,Yongjun Wang +14 more
TL;DR: This study evaluated the effect of Lp-PLA2 activity on dual antiplatelet therapy efficacy and safety in minor stroke or transient ischemic attack patients with CYP2C19 loss-of-function alleles, finding no significant interaction effect on stroke recurrence or bleeding risk.